Literature DB >> 17406243

COBRA: combined binary ratio labeling of nucleic-acid probes for multi-color fluorescence in situ hybridization karyotyping.

Karoly Szuhai1, Hans J Tanke.   

Abstract

Combined binary ratio labeling (COBRA) is designed to increase the multiplicity of fluorescence in situ hybridization (FISH)--i.e., the number of targets that can be distinguished simultaneously. In principle, chemical (ULS), enzymatic (nick translation or random priming) or PCR-based labeling procedures of probes can be used. The method was originally designed to label chromosome-painting probes, but has also been used for probe sets specific for subtelomeric regions. COBRA imaging requires a digital fluorescence microscope equipped for sequential excitation and recording of color images. Staining of all 24 human chromosomes is accomplished with only four fluorochromes, compared with five for methods based on combinatorial labeling. The COBRA procedure takes approximately 6 h laboratory work, 2-3 d incubation and a few hours imaging. The method is routinely applied in research (cultured cells from human or mouse origin) or to support clinical diagnosis, such as postnatal and perinatal genetic testing and in solid tumors.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17406243     DOI: 10.1038/nprot.2006.41

Source DB:  PubMed          Journal:  Nat Protoc        ISSN: 1750-2799            Impact factor:   13.491


  29 in total

1.  Adenoviral vector DNA for accurate genome editing with engineered nucleases.

Authors:  Maarten Holkers; Ignazio Maggio; Sara F D Henriques; Josephine M Janssen; Toni Cathomen; Manuel A F V Gonçalves
Journal:  Nat Methods       Date:  2014-08-24       Impact factor: 28.547

2.  Establishment and characterization of a new human myxoid liposarcoma cell line (DL-221) with the FUS-DDIT3 translocation.

Authors:  Marieke A de Graaff; Jamie S E Yu; Hannah C Beird; Davis R Ingram; Theresa Nguyen; Jeffrey Juehui Liu; Svetlana Bolshakov; Károly Szuhai; Pierre Åman; Keila E Torres; Dina Lev; Torsten O Nielsen; Judith V M G Bovée; Alexander J Lazar; Neeta Somaiah
Journal:  Lab Invest       Date:  2016-06-06       Impact factor: 5.662

3.  Heterogeneous and complex rearrangements of chromosome arm 6q in chondromyxoid fibroma: delineation of breakpoints and analysis of candidate target genes.

Authors:  Salvatore Romeo; Ronald A J Duim; Julia A Bridge; Fredrik Mertens; Danielle de Jong; Paola Dal Cin; Pauline M Wijers-Koster; Maria Debiec-Rychter; Raf Sciot; Andrew E Rosenberg; Karoly Szuhai; Pancras C W Hogendoorn
Journal:  Am J Pathol       Date:  2010-08-09       Impact factor: 4.307

4.  Characterization of a new human cell line (CH-3573) derived from a grade II chondrosarcoma with matrix production.

Authors:  Silvia Calabuig-Fariñas; Rosario Gil Benso; Karoly Szuhai; Isidro Machado; José Antonio López-Guerrero; Danielle de Jong; Amando Peydró; Teresa San Miguel; Lara Navarro; Antonio Pellín; Antonio Llombart-Bosch
Journal:  Pathol Oncol Res       Date:  2012-02-15       Impact factor: 3.201

5.  Selective resistance to the PARP inhibitor olaparib in a mouse model for BRCA1-deficient metaplastic breast cancer.

Authors:  Linda Henneman; Martine H van Miltenburg; Ewa M Michalak; Tanya M Braumuller; Janneke E Jaspers; Anne Paulien Drenth; Renske de Korte-Grimmerink; Ewa Gogola; Karoly Szuhai; Andreas Schlicker; Rahmen Bin Ali; Colin Pritchard; Ivo J Huijbers; Anton Berns; Sven Rottenberg; Jos Jonkers
Journal:  Proc Natl Acad Sci U S A       Date:  2015-06-22       Impact factor: 11.205

6.  Kinome profiling of myxoid liposarcoma reveals NF-kappaB-pathway kinase activity and casein kinase II inhibition as a potential treatment option.

Authors:  Stefan M Willems; Yvonne M Schrage; Inge H Briaire-de Bruijn; Karoly Szuhai; Pancras C W Hogendoorn; Judith V M G Bovée
Journal:  Mol Cancer       Date:  2010-09-23       Impact factor: 27.401

7.  Evaluation of high-resolution microarray platforms for genomic profiling of bone tumours.

Authors:  Stine H Kresse; Karoly Szuhai; Ana H Barragan-Polania; Halfdan Rydbeck; Anne-Marie Cleton-Jansen; Ola Myklebost; Leonardo A Meza-Zepeda
Journal:  BMC Res Notes       Date:  2010-08-08

8.  Oncogenic functions of hMDMX in in vitro transformation of primary human fibroblasts and embryonic retinoblasts.

Authors:  Kristiaan Lenos; Job de Lange; Amina F A S Teunisse; Kirsten Lodder; Matty Verlaan-de Vries; Eliza Wiercinska; Marja J M van der Burg; Karoly Szuhai; Aart G Jochemsen
Journal:  Mol Cancer       Date:  2011-09-12       Impact factor: 27.401

9.  A balanced t(5;17) (p15;q22-23) in chondroblastoma: frequency of the re-arrangement and analysis of the candidate genes.

Authors:  Salvatore Romeo; Karoly Szuhai; Isao Nishimori; Marije Ijszenga; Pauline Wijers-Koster; Antonie H M Taminiau; Pancras C W Hogendoorn
Journal:  BMC Cancer       Date:  2009-11-10       Impact factor: 4.430

10.  Intrinsic epigenetic regulation of the D4Z4 macrosatellite repeat in a transgenic mouse model for FSHD.

Authors:  Yvonne D Krom; Peter E Thijssen; Janet M Young; Bianca den Hamer; Judit Balog; Zizhen Yao; Lisa Maves; Lauren Snider; Paul Knopp; Peter S Zammit; Tonnie Rijkers; Baziel G M van Engelen; George W Padberg; Rune R Frants; Rabi Tawil; Stephen J Tapscott; Silvère M van der Maarel
Journal:  PLoS Genet       Date:  2013-04-04       Impact factor: 5.917

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.